ID | Name | Number of studies | |
---|---|---|---|
CL_0000186 | myofibroblast cell | 24 | |
CL_0000183 | contractile cell | 0 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
---|---|---|---|---|---|
EMILIN1 | 12 | 38% ± 17% | 0 | 5 | |
CNN1 | 10 | 41% ± 22% | 1 | 6 | |
PDGFRA | 9 | 37% ± 13% | 1 | 5 | |
COL6A3 | 14 | 50% ± 22% | 2 | 9 | |
TGFB1I1 | 14 | 51% ± 21% | 2 | 10 | |
MFAP4 | 13 | 64% ± 27% | 2 | 7 | |
MYH11 | 12 | 58% ± 23% | 2 | 7 | |
MXRA8 | 12 | 38% ± 11% | 2 | 7 | |
LMOD1 | 11 | 32% ± 10% | 2 | 8 | |
CAVIN3 | 11 | 36% ± 11% | 2 | 15 | |
PCOLCE | 10 | 43% ± 14% | 2 | 7 | |
LUM | 10 | 56% ± 25% | 2 | 8 | |
ACTA2 | 16 | 77% ± 16% | 3 | 8 | |
CRISPLD2 | 13 | 45% ± 13% | 3 | 9 | |
EFEMP2 | 12 | 41% ± 14% | 3 | 12 | |
SYNPO2 | 12 | 37% ± 19% | 3 | 12 | |
MMP2 | 12 | 50% ± 20% | 3 | 13 | |
PDLIM3 | 12 | 45% ± 17% | 3 | 14 | |
GEM | 11 | 40% ± 15% | 3 | 10 | |
FXYD1 | 11 | 37% ± 12% | 3 | 11 | |
ELN | 11 | 48% ± 15% | 3 | 12 | |
TAGLN | 16 | 78% ± 19% | 4 | 17 | |
PDLIM7 | 15 | 51% ± 19% | 4 | 16 | |
KANK2 | 14 | 33% ± 12% | 4 | 12 | |
CCN2 | 14 | 50% ± 25% | 4 | 22 | |
ADAMTS1 | 13 | 40% ± 15% | 4 | 17 | |
COX7A1 | 13 | 29% ± 10% | 4 | 23 | |
COL5A2 | 12 | 38% ± 18% | 4 | 17 | |
DCN | 12 | 75% ± 26% | 4 | 17 | |
NBL1 | 12 | 39% ± 17% | 4 | 19 |
GO_0072144 | Biological process | glomerular mesangial cell development |
GO_0007178 | Biological process | cell surface receptor protein serine/threonine kinase signaling pathway |
GO_0006998 | Biological process | nuclear envelope organization |
GO_0090382 | Biological process | phagosome maturation |
GO_0061061 | Biological process | muscle structure development |
GO_1902430 | Biological process | negative regulation of amyloid-beta formation |
GO_0072051 | Biological process | juxtaglomerular apparatus development |
GO_0043279 | Biological process | response to alkaloid |
GO_0001560 | Biological process | regulation of cell growth by extracellular stimulus |
GO_0030948 | Biological process | negative regulation of vascular endothelial growth factor receptor signaling pathway |
GO_0099553 | Biological process | trans-synaptic signaling by endocannabinoid, modulating synaptic transmission |
GO_1905072 | Biological process | cardiac jelly development |
GO_0060157 | Biological process | urinary bladder development |
GO_0030241 | Biological process | skeletal muscle myosin thick filament assembly |
GO_0048660 | Biological process | regulation of smooth muscle cell proliferation |
GO_0031032 | Biological process | actomyosin structure organization |
GO_0003231 | Biological process | cardiac ventricle development |
GO_0060596 | Biological process | mammary placode formation |
GO_1905522 | Biological process | negative regulation of macrophage migration |
GO_0060414 | Biological process | aorta smooth muscle tissue morphogenesis |
GO_0036302 | Biological process | atrioventricular canal development |
GO_0097070 | Biological process | ductus arteriosus closure |
GO_0003105 | Biological process | negative regulation of glomerular filtration |
GO_0048251 | Biological process | elastic fiber assembly |
GO_0060538 | Biological process | skeletal muscle organ development |
GO_0086036 | Biological process | regulation of cardiac muscle cell membrane potential |
GO_0090131 | Biological process | mesenchyme migration |
GO_0045661 | Biological process | regulation of myoblast differentiation |
GO_0019695 | Biological process | choline metabolic process |
GO_1900426 | Biological process | positive regulation of defense response to bacterium |
Cell type name | myofibroblast cell |
Synonyms | MFB |
Description | An animal cell that has characteristics of both a fibroblast cell and a smooth muscle cell. |
Parent | CL_0000183 |